GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Price-to-Funds-From-Operations

Actinogen Medical (ASX:ACW) Price-to-Funds-From-Operations : (As of Jun. 09, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Actinogen Medical (ASX:ACW) Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.